Skip to main content
VCbacked
Log inGet Started

SecondWave Systems

Minneapolis, United States

SecondWave Systems is an ultrasound stimulation platform.

$7.0M raised
Apr 2025
Series A
Health Care

Top Investors

Treo VenturesAdvanced Research Projects Agency for HealthScientific Health Development PartnersUniversity of Minnesota Discovery Capital InvestmentSSBCI fund

Founder Contacts

19,000+ verified contacts
Get Instant Access

Emails, phones & LinkedIn profiles

Frequently Asked Questions about SecondWave Systems

How much funding has SecondWave Systems raised?
SecondWave Systems has raised $7.0M in total funding. The most recent round was Series A. The last funding was announced in April 2025.
Who are SecondWave Systems's investors?
SecondWave Systems's investors include Treo Ventures, Advanced Research Projects Agency for Health, Scientific Health Development Partners, University of Minnesota Discovery Capital Investment, SSBCI fund.
Where is SecondWave Systems headquartered?
SecondWave Systems is headquartered in Minneapolis, United States.
What does SecondWave Systems do?
SecondWave Systems is an ultrasound stimulation platform.
What stage is SecondWave Systems at?
SecondWave Systems is at the Series A stage.
Cite this page

Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated .

MLA
"SecondWave Systems — Funding & Investors." VCBacked, April 8, 2025, https://www.vcbacked.co/company/secondwave-systems. Accessed June 4, 2026.
APA
VCBacked. (2025). SecondWave Systems — Funding & Investors. Retrieved June 4, 2026, from https://www.vcbacked.co/company/secondwave-systems
Wikipedia (cite web)
{{cite web |title=SecondWave Systems — Funding & Investors |url=https://www.vcbacked.co/company/secondwave-systems |website=VCBacked |access-date=June 4, 2026}}

Profile data sourced and verified per the VCBacked methodology. Last funding round dated .

Similar Companies in Health Care

View all
Virtuoso Surgical
Nashville
Basata
Phoenix
Pharvaris
Zug
Odyssey Therapeutics
Boston$213.0M
Tempus
Chicago
Sedivention
Munich$848K